JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/17.01.25 Stock

Warrant

DE000JL1KNG2

Real-time Bid/Ask 07:17:17 2024-07-12 am EDT
1.97 EUR / 2.07 EUR 0.00% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/17.01.25
Current month+16.09%
1 month+39.31%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 1.96 -2.97%
24-07-11 2.02 -2.88%
24-07-10 2.08 +9.47%
24-07-09 1.9 +2.70%
24-07-08 1.85 0.00%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 02:59 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNG
ISINDE000JL1KNG2
Date issued 2023-04-05
Strike 225 $
Maturity 2025-01-17 (189 Days)
Parity 10 : 1
Emission price 1.59
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.07
Lowest since issue 1.4
Spread 0.1
Spread %4.83%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
224.9 USD
Average target price
277.8 USD
Spread / Average Target
+23.50%
Consensus